Search
for
Sort by
Research 121–150 of 351
- The pioneer factor SOX9 competes for epigenetic factors to switch stem cell fates
- Deep phenotyping of skin tissue remodeling in patients with systemic sclerosis treated with CD19-CAR T cells
- AI-driven biomaterial design: an intelligent closed loop from reverse design to biological response
- Global Landscapes of Human Phenotypic Variation in Inherited Traits
- Scalp Bacterial Microbiota Dysbiosis in Androgenetic Alopecia: Community Structure, Functional Profiles, and Associations with Lifestyle Factors
- Кореляційний аналіз взаємозв’язку хронічних дерматозів із соматичною патологією та обґрунтування детоксикаційної терапії
- Platelet Concentrates in Regenerative Medicine: A Comparative Review of Platelet-Rich Plasma, Platelet-Rich Fibrin, and Concentrated Growth Factors
- Development and Evaluation of a Niosome-Integrated Microneedle System for Targeted Follicular Delivery of Ketoconazole in Alopecia Therapy
- Evidence Synthesis Gone Awry: The Perils of Aggregating Ineffective or Unsafe Doses in Alopecia Areata Reviews
- sc-eQTL unveil immunogenetic architecture of polycystic ovary syndrome
- Grand challenges in dermatologic drug discovery: four priorities to transform skin disease treatment
- Metabolomic and lipidomic atlas of human hair across its length
- Multi-ancestry tandem repeat association study of hair colour using exome-wide sequencing
- Use of modern technological devices (photography, mobile phone applications and artificial intelligence) in dermatology
- Effect of Exercise Interventions on Metabolic, Reproductive and Mental Health in Overweight Women with Polycystic Ovary Syndrome
- FRI0157 OBSERVATIONAL STUDY OF HAIR FALL IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH LOW DOSE METHOTREXATE COMPARED TO HEALTHY CONTROLS
- The Clinical Presentation of Systemic Lupus Erythematosus
- Decoding Hyperpigmentation from Biological Mechanisms to Actives with Clinically Proven Topical Efficacy: A Narrative Review
- Real-world safety of ixekizumab: a disproportionality analysis using the FDA adverse event reporting system and the VigiAccess databases
- Adverse event reporting of four anti-Calcitonin gene-related peptide monoclonal antibodies for migraine prevention: a real-world study based on the FDA adverse event reporting system
- The Relative Efficacy and Safety of Monotherapies for Alopecia Areata: A Network Meta‐Analysis Study
- Real-world safety of Tepotinib: Insights from the Food and Drug Administration Adverse Event Reporting System
- Drug-induced vitiligo: a real-world pharmacovigilance analysis of the FAERS database
- Assessing the safety of topical minoxidil through disproportionality analysis of FAERS reports
- Multidimensional assessment of adverse events of finasteride:a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024
- Evidence-based consensus on the clinical application of photobiomodulation
- Patient, Oncologist, and Payer Preferences for Adjuvant Endocrine Therapy and CDK4/6 Inhibitor Regimens in Early-Stage Breast Cancer: A Discrete Choice Experiment
- Effects of different traditional Chinese exercise in the treatment of essential hypertension: a systematic review and network meta-analysis
- The Economic Burden of Alopecia Areata in Romania
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study